Robert Van Nostrand

Track

Insider profile

Currently holds positions in Yield10 Bioscience Inc, Enumeral Biomedical Holdings Inc and Intra-Cellular Therapies Inc

Performance

Overall performance
3.7
Performance over holding periods
3.7
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
5 20% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board, Independent Director Yield10 Bioscience Inc Jan. 1, 2013 -
Director Enumeral Biomedical Holdings Inc Dec. 4, 2014 -
Lead Independent Director Intra-Cellular Therapies Inc Jan. 1, 2017 -
Independent Director Achillion Pharmaceuticals Inc April 27, 2007 - Jan. 28, 2020
Independent Director Intra-Cellular Therapies Inc Jan. 1, 2014 - Jan. 1, 2017
Independent Director Yield10 Bioscience Inc Oct. 1, 2006 - Jan. 1, 2013
Robert Van Nostrand's trades of Sellas Life Sciences Group Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
75.85
Quantity 20,000
Value US$1,516,919
Transaction date
Proposed sale
Price
72.87
Quantity 20,000
Value US$1,457,387
Transaction date
Sale
Price
73.51
Quantity 562 -10.5%
Value US$41,313
Transaction date
Sale
Price
73.50
Quantity 1,492 -21.9%
Value US$109,662
Transaction date
Sale
Price
73.42
Quantity 321 -4.5%
Value US$23,569
Transaction date
Sale
Price
72.93
Quantity 95 -1.3%
Value US$6,928
Transaction date
Sale
Price
72.62
Quantity 49 -0.7%
Value US$3,559
Transaction date
Sale
Price
72.55
Quantity 48 -0.7%
Value US$3,482
Transaction date
Sale
Price
72.51
Quantity 112 -1.5%
Value US$8,122
Transaction date
Sale
Price
72.50
Quantity 71 -0.9%
Value US$5,148
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-06-13 2025-06-12
B Purchase
75,915 -46.6%
131.19
US$4,728,099 		75,915 -46.6% 131.19 US$4,728,099
2024-06-21 2024-06-18
PlS Planned sale
66,666 -46.9%
39.17
US$3,321,459 		66,666 -46.9% 39.17 US$3,321,459
2024-06-21 2024-06-18
PlS Planned sale
64,676 -45.0%
408.52
US$137,334 		64,676 -45.0% 408.52 US$137,334
2024-06-18 2024-06-18
PrS Proposed sale
20,000
75.85
US$1,516,919 		20,000 75.85 US$1,516,919
2024-02-28 2024-02-27
S Sale
10,349 -51.8%
73.14
US$756,926 		10,349 -51.8% 73.14 US$756,926
2024-02-28 2024-02-27
S Sale
9,651 -32.6%
72.71
US$701,724 		9,651 -32.6% 72.71 US$701,724
2024-02-27 2024-02-27
PrS Proposed sale
20,000
72.87
US$1,457,387 		20,000 72.87 US$1,457,387
2023-04-19 2023-04-17
PlS Planned sale
10,000 -51.7%
63.00
US$630,000 		10,000 -51.7% 63.00 US$630,000
2022-08-12 2022-08-11
S Sale
1,500 -14.2%
56.80
US$85,200 		1,500 -14.2% 56.80 US$85,200
2022-08-12 2022-08-11
S Sale
28,500 -73.0%
57.15
US$1,628,775 		28,500 -73.0% 57.15 US$1,628,775
2004-10-05 2004-10-01
PlS Planned sale
111 -2.3%
61.83
US$6,863 		111 -2.3% 61.83 US$6,863
2004-10-05 2004-10-01
PlS Planned sale
25 -0.5%
61.75
US$1,544 		25 -0.5% 61.75 US$1,544
2004-10-05 2004-10-01
PlS Planned sale
197 -3.9%
61.60
US$12,135 		197 -3.9% 61.60 US$12,135
2004-10-05 2004-10-01
PlS Planned sale
99 -1.9%
61.55
US$6,093 		99 -1.9% 61.55 US$6,093
2004-10-05 2004-10-01
PlS Planned sale
49 -0.9%
61.30
US$3,004 		49 -0.9% 61.30 US$3,004
2004-10-05 2004-10-01
PlS Planned sale
12 -0.2%
61.25
US$735 		12 -0.2% 61.25 US$735
2004-10-05 2004-10-01
PlS Planned sale
12 -0.2%
61.19
US$734 		12 -0.2% 61.19 US$734
2004-10-05 2004-10-01
PlS Planned sale
49 -0.9%
61.18
US$2,998 		49 -0.9% 61.18 US$2,998
2004-10-05 2004-10-01
PlS Planned sale
12 -0.2%
61.11
US$733 		12 -0.2% 61.11 US$733
2004-10-05 2004-10-01
PlS Planned sale
320 -5.7%
61.10
US$19,552 		320 -5.7% 61.10 US$19,552
2004-10-05 2004-10-01
PlS Planned sale
37 -0.7%
61.09
US$2,260 		37 -0.7% 61.09 US$2,260
2004-10-05 2004-10-01
PlS Planned sale
49 -0.9%
61.07
US$2,992 		49 -0.9% 61.07 US$2,992
2004-10-05 2004-10-01
PlS Planned sale
37 -0.6%
61.05
US$2,259 		37 -0.6% 61.05 US$2,259
2004-10-05 2004-10-01
PlS Planned sale
287 -4.7%
61.00
US$17,507 		287 -4.7% 61.00 US$17,507
2004-10-05 2004-10-01
PlS Planned sale
1,231 -16.9%
60.96
US$75,042 		1,231 -16.9% 60.96 US$75,042
2004-10-05 2004-10-01
PlS Planned sale
12 -0.2%
60.83
US$730 		12 -0.2% 60.83 US$730
2004-10-05 2004-10-01
PlS Planned sale
25 -0.3%
60.81
US$1,520 		25 -0.3% 60.81 US$1,520
2004-10-05 2004-10-01
PlS Planned sale
62 -0.8%
60.80
US$3,770 		62 -0.8% 60.80 US$3,770
2004-10-05 2004-10-01
PlS Planned sale
12 -0.2%
60.78
US$729 		12 -0.2% 60.78 US$729
2004-10-05 2004-10-01
PlS Planned sale
25 -0.3%
60.77
US$1,519 		25 -0.3% 60.77 US$1,519
2004-10-05 2004-10-01
PlS Planned sale
38 -0.5%
60.76
US$2,309 		38 -0.5% 60.76 US$2,309
2004-10-05 2004-10-01
PlS Planned sale
49 -0.7%
60.75
US$2,977 		49 -0.7% 60.75 US$2,977
2004-07-02 2004-07-01
PlS Planned sale
18 -0.4%
70.00
US$1,260 		18 -0.4% 70.00 US$1,260
2004-07-02 2004-07-01
PlS Planned sale
48 -1.0%
69.97
US$3,359 		48 -1.0% 69.97 US$3,359
2004-07-02 2004-07-01
PlS Planned sale
240 -4.7%
69.96
US$16,790 		240 -4.7% 69.96 US$16,790
2004-07-02 2004-07-01
PlS Planned sale
1,997 -28.3%
69.95
US$139,690 		1,997 -28.3% 69.95 US$139,690
2004-07-02 2004-07-01
PlS Planned sale
447 -5.9%
69.52
US$31,075 		447 -5.9% 69.52 US$31,075
2004-05-05 2004-05-03
S Sale
562 -10.5%
73.51
US$41,313 		562 -10.5% 73.51 US$41,313
2004-05-05 2004-05-03
S Sale
1,492 -21.9%
73.50
US$109,662 		1,492 -21.9% 73.50 US$109,662
2004-05-05 2004-05-03
S Sale
321 -4.5%
73.42
US$23,569 		321 -4.5% 73.42 US$23,569
2004-05-05 2004-05-03
S Sale
95 -1.3%
72.93
US$6,928 		95 -1.3% 72.93 US$6,928
2004-05-05 2004-05-03
S Sale
49 -0.7%
72.62
US$3,559 		49 -0.7% 72.62 US$3,559
2004-05-05 2004-05-03
S Sale
48 -0.7%
72.55
US$3,482 		48 -0.7% 72.55 US$3,482
2004-05-05 2004-05-03
S Sale
112 -1.5%
72.51
US$8,122 		112 -1.5% 72.51 US$8,122
2004-05-05 2004-05-03
S Sale
71 -0.9%
72.50
US$5,148 		71 -0.9% 72.50 US$5,148